/
RSS Feed
ORLANDO—Evidence that cancer could be controlled more effectively by blocking two molecular pathways simultaneously was reported at the American Association for Cancer Research annual meeting in Orlando, Florida. Johanna Bendell from the Sarah Cannon Research Institute in Nashville, Tennessee discusses her group’s findings in research using inhibitors of both the P13K-AKT-mTOR and RAS-RAF-MEK pathways in a group of patients with a range of different advanced solid tumours.
LISTEN
[audio:https://www.audiomedica.com/podcasting/ecancer/110404JohannaBendellPODCASTLoRes.mp3]
